Medicaid “Best Price” May Be Avenue To Challenge “Authorized” Generics
Executive Summary
FDA's decision not to block "authorized" generic agreements may prompt interest in exploring Medicaid "best price" reporting requirements as another avenue for ending the practice
You may also be interested in...
“Authorized” Generics Will Be Subject To “Best Price” Calculations – CMS
The Centers for Medicare & Medicaid Services is indicating that it will consider "authorized" generics to be brand drugs for the purposes of best price reporting
“Authorized” Generics Will Be Subject To “Best Price” Calculations – CMS
The Centers for Medicare & Medicaid Services is indicating that it will consider "authorized" generics to be brand drugs for the purposes of best price reporting
GPhA Seeks Change On Medicaid “Best Price” For “Authorized” Generics
The Generic Pharmaceutical Association's challenge to "authorized" generics includes pushing for a change in how the Medicaid "best price" for a branded product and its authorized generic are reported